MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-28-2026
argenx SE Historical Prices 2011-2026 | ARGX
Annual Historical Prices argenx SE
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 615 | 394 | 490 | 269 | 293 | 144 | 106 | 77.6 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 615 | 77.6 | 299 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 3.59 | -1.24 % | $ 1.07 B |  Canada |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
ADMA Biologics
ADMA
|
15.9 | $ 15.71 | -5.02 % | $ 3.74 B | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
22 | $ 20.29 | 2.17 % | $ 2.56 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
61.9 | $ 75.95 | -0.76 % | $ 1.47 B | USA |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.5 | -7.98 % | $ 383 M | Britain |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
36.1 | $ 34.35 | -3.74 % | $ 3.57 B | USA |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
10.4 | $ 7.99 | -5.17 % | $ 34.6 M | USA |
 |
CorMedix
CRMD
|
3.42 | $ 6.35 | -10.88 % | $ 323 M | USA |
 |
Champions Oncology
CSBR
|
7.75 | $ 5.79 | -3.58 % | $ 79.1 M | USA |
 |
Axsome Therapeutics
AXSM
|
174 | $ 160.64 | -2.1 % | $ 7.99 B | USA |
 |
BridgeBio Pharma
BBIO
|
68.4 | $ 65.51 | -1.55 % | $ 12.5 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Denali Therapeutics
DNLI
|
18.5 | $ 19.73 | -3.17 % | $ 3.25 B | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Edesa Biotech
EDSA
|
1.9 | $ 3.71 | -13.11 % | $ 11.9 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Equillium
EQ
|
2.44 | $ 1.79 | 2.29 % | $ 62.2 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
2.65 | $ 2.75 | -1.96 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
61 | $ 60.6 | 0.28 % | $ 11.6 B | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 8.26 | -1.31 % | $ 1.36 B | Britain |